Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Solid Tumor × 5'-Nucleotidase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

Injections 25 pembrolizumab 13 toripalimab 12 tislelizumab 9 Gemcitabine 7 Cisplatin 7 Carboplatin 6 atezolizumab 5 Oxaliplatin 5 Nivolumab 5 Leucovorin 5 Irinotecan 5 Fluorouracil 5 Pemetrexed 4 Paclitaxel 4 Docetaxel 4 Cetuximab 4 trastuzumab deruxtecan 3 spartalizumab 3 cediranib 3 PM 01183 3 Capecitabine 3 Bevacizumab 3 sintilimab 2 olaparib 2 lenvatinib 2 glumetinib 2 camrelizumab 2 apatinib 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05950815 2023-07-18

A Study of PM1015 in Patients With Advanced Solid Tumors

Biotheus Inc.

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡